Abeona Therapeutics (ABEO) Tax Provisions (2024 - 2026)

Abeona Therapeutics (ABEO) posted quarterly Tax Provisions of $2000.0 for Q1 2026, down 99.99% quarter-over-quarter from $14.7 million in Q4 2025.

Abeona Therapeutics (ABEO) Tax Provisions (2024 - 2026) Analysis & Trends

Abeona Therapeutics' Tax Provisions history runs 3 years deep, the most recent figure standing at $2000.0 for Q1 2026.

In Q1 2026, Tax Provisions changed N/A year-over-year to $2000.0; the TTM figure through Mar 2026 stood at -$1.2 million (changed N/A YoY), while the FY2025 annual figure was $15.0 million, up 2304.71% from the prior year.
Tax Provisions for Q1 2026 stood at $2000.0, down from $14.7 million in the prior quarter.
The five-year high for Tax Provisions was $14.7 million in Q4 2025, with the low at -$15.2 million in Q3 2025.
The 3-year median for Tax Provisions is -$338500.0 (2024), against an average of -$304750.0.
Peak annual rise in Tax Provisions reached 2258.32% in 2025, while the deepest fall reached 2258.32% in 2025.
Abeona Therapeutics' Tax Provisions stood at -$679000.0 in 2024, then jumped by 2258.32% to $14.7 million in 2025, then tumbled by 99.99% to $2000.0 in 2026.
Business Quant data shows ABEO's Tax Provisions at $2000.0 in Q1 2026, $14.7 million in Q4 2025, and -$15.2 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	59.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	75.45 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	267.73
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	13.31 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	1.90 Mn
10	Abeona Therapeutics	342.78 Mn	195.96 Mn	7.20 Mn	-

Download Data